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Brucellosis, a zoonotic disease, was made statutorily notifi-
able in China in 1955. We analyzed the incidence and spa-
tial–temporal distribution of human brucellosis during 1955–
2014 in China using notifiable surveillance data: aggregated 
data for 1955–2003 and individual case data for 2004–2014. 
A total of 513,034 brucellosis cases were recorded, of which 
99.3% were reported in northern China during 1955–2014, 
and 69.1% (258, 462/374, 141) occurred during Febru-
ary–July in 1990–2014. Incidence remained high during 
1955–1978 (interquartile range 0.42–1.0 cases/100,000 
residents), then decreased dramatically in 1979–1994. 
However, brucellosis has reemerged since 1995 (interquar-
tile range 0.11–0.23 in 1995–2003 and 1.48–2.89 in 2004–
2014); the historical high occurred in 2014, and the affected 
area expanded from northern pastureland provinces to the 
adjacent grassland and agricultural areas, then to southern 
coastal and southwestern areas. Control strategies in China 
should be adjusted to account for these changes by adopt-
ing a One Health approach.
Brucellosis is a bacterial zoonosis caused by Brucella spp., which can be transmitted from animal reservoirs, 
such as cattle, sheep, goats, and pigs, to humans through 
direct contact with infected animals or ingestion of unpas-
teurized animal products (1–3). The global epidemiology of 
brucellosis has drastically changed over the past decades, 
particularly in industrialized countries where the disease 
was previously endemic but is now mainly associated with 
returning travelers. However, brucellosis remains a serious 
concern in low- and middle-income countries, which have 
most new human cases globally (estimated ≈500,000 cases 
annually) and major economic losses in animal production 
resulting from the adverse effects of infection on livestock 
reproduction (2,4,5). Additionally, human brucellosis is of 
particular concern because of high initial treatment failure, 
substantial residual disability of infected patients, and re-
lapse rates (1,6). Moreover, Brucella spp. are highly infec-
tious through the aerosol route, making them a potential 
agent of biological weapons and bioterrorism (7).
In China, brucellosis was first recorded as Malta fever 
for 2 foreigners in Shanghai in 1905, but several patients 
in China who had similar clinical symptoms had been ob-
served in the 10 years before this report (8). After this re-
port, 3 cases were reported from Chongqing in 1906 (9). 
The first person with a definite diagnosis of Brucella infec-
tion by serologic tests was reported from Fujian in 1916 
(10). Subsequently, Brucella sp. was isolated from a for-
eigner and his goats who traveled from Punjab, India, to 
Henan Province, China, in 1925 (11), and human infection 
in a laboratory setting was reported in Beijing in 1936 (12). 
Thus, human brucellosis was seen in China before 1950, 
especially in the northern provinces (13).
Since 1950, activities for prevention and control of 
brucellosis have been gradually introduced in mainland 
China (14,15). During 1950–1963, the reporting for human 
brucellosis was established nationwide, and some surveys 
were conducted. Vaccination for animals and humans was 
implemented as the main control measure during 1964–
1976 in regions with severe epidemics, such as Inner Mon-
golia, Xinjiang, Qinghai, Ningxia, and Henan Provinces 
(14). During 1977–1988, a national program for brucellosis 
control was conducted with the introduction of diagnostic 
criteria, treatment protocols, and control measures, and 
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vaccination of domestic animals was used as the main con-
trol measure. National sentinel surveillance was established 
in 1990 to monitor the seroprevalence of brucellosis in hu-
mans and animals (16).
During the past decade, outbreaks of human brucel-
losis have been reported in increasing numbers and with an 
apparent geographic expansion from the historically affect-
ed north of China (17,18) to southern provinces where non-
occupational exposure might be more common because of 
the increasing movement of humans, animals, and animal 
food products from brucellosis-endemic regions (19–21). 
The epidemiology of human brucellosis clearly presented 
major challenges in China during the past 60 years, but 
studies reporting the spatial–temporal patterns of human 
brucellosis with high-quality, nationwide incidence data 
are lacking (2,4,14,22,23). We describe the magnitude and 
distribution of human brucellosis in mainland China using 
the notifiable reporting data for 1955–2014 and emphasize 
its recent reemergence. Improving our understanding of the 
changing epidemiology of brucellosis and identifying high-
risk areas can help in formulating plans for national strate-
gies to prevent and control brucellosis.
Methods
Data Source and Ethical Considerations
On July 5, 1955, human brucellosis was made statutorily 
notifiable in China: all probable or laboratory-confirmed 
new brucellosis cases were required to be reported (on-
line Technical Appendix Table 1, https://wwwnc.cdc.gov/
EID/article/23/3/16-1710-Techapp1.pdf). In this study, 
we used 2 datasets because the requirements for report-
ing changed during the study period (24). One comprises 
the number of brucellosis cases aggregated by case-pa-
tient sex, age group, and occupation; incidence rate; death 
rate; and case-fatality ratio (online Technical Appendix 
Table 2), reported monthly through paper-based post or 
electronic files during 1955–2003. The other consists of 
individual brucellosis cases reported by doctors within 
24 hours after diagnosis to the online National Notifi-
able Infectious Disease Reporting Information System at 
the Chinese Center for Disease Control and Prevention 
during 2004–2014. (Variables in individual datasets are 
available in online Technical Appendix Table 3.) All data 
used in this study were anonymized so that individual pa-
tients could not be identified.
The National Health and Family Planning Commis-
sion of China determined that the collection of data from 
human cases of brucellosis was part of continuing public 
health surveillance of a notifiable infectious disease and 
was exempt from institutional review board assessment. 
All data were supplied and analyzed in an anonymous for-
mat, without access to personal identifying information.
Case Definition
Brucellosis cases have been classified as probable (clini-
cally diagnosed) or confirmed (laboratory confirmed) in 
accordance with the guidelines for human brucellosis di-
agnosis issued by the Chinese national health authorities in 
1977, 1988, 1996, and 2007, which were successively used 
during 1977–2014 (online Technical Appendix Table 4). 
Probable cases are diagnosed by local experienced physi-
cians according to patient anamnesis, epidemiologic expo-
sure, clinical manifestations, and/or positive results of pre-
sumptive laboratory tests, including the plate agglutination 
test and the intradermal allergic reaction test. Confirmed 
cases are probable cases with 1 positive result of the fol-
lowing tests: standard tube agglutination test, complement 
fixation test, Coombs test, cysteine test for serologic diag-
nosis, or positive Brucella spp. isolation (1).
Data Analysis
Our analysis comprised all probable and confirmed cases 
in persons with illness onset from January 1, 1955, through 
December 31, 2014. According to the National Mid-term 
and Long-term Animal Disease Control Plan of China (25), 
all the provinces in northern China were identified as the 
key regions for brucellosis control. Therefore, we aggre-
gated the surveillance data of each province to northern 
and southern China (online Technical Appendix Table 5), 
as previously reported (26), to examine spatial–temporal 
patterns by region. To eliminate the potential effect of the 
introduction of Internet-based reporting on the increasing 
number of cases since 2004, we made a time-series predic-
tion of the number of cases in 2004 on the basis of data for 
1993–2003, using the Holt exponential smoothing method 
with a 95% CI (27). Then we compared the upper value 
of the 95% CI with the actual number of cases in 2004 to 
calculate the excess proportion of cases that might have 
contributed to improved data reporting. Adjusted incidence 
rates for 2004–2014 were estimated by using this excess 
proportion and plotted as an epidemic curve. We also pre-
dicted the monthly numbers of cases during the next 5 
years (2015–2019) by Holt-Winters exponential smoothing 
on the basis of data reported during 2004–2014 to explore 
the trend of incidence with seasonality (27).
We created a heat map of the yearly incidence rate 
to visualize the long-term change over the 60-year period 
by province. We also created a heat map of the monthly 
number of cases reported during 2005–2014 by province, 
standardized by the yearly number in each province, and 
plotted a heat map of average weekly proportions of case 
numbers by province to explore the seasonal pattern during 
2005–2014. To test the differences between northern and 
southern China, we used Mann-Whitney U tests with a sig-
nificance level of α = 0.05 to test for differences in the time 
from illness onset to diagnosis and χ2 with a significance 
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level of α = 0.05 to test the differences in the proportion of 
imported cases. The R statistical software (version 3.1.2, 
R Foundation for Statistical Computing, Vienna, Austria) 
with the package forecast (version 6.1), was used to pro-
duce the graphs and heat maps and to perform statistical 
analyses and prediction, and ArcGIS 10.2.2 (ESRI, Red-
lands, CA, USA) was used to plot the geographic patterns.
Results
Demographic Features
During 1955–2014, a total of 513,034 human brucello-
sis cases (median 3,504/year [interquartile range (IQR) 
1,145–7,886]), including 170 deaths, were reported to the 
national human brucellosis surveillance system in main-
land China (Figure 1, panel A). Among them, 346,682 
(67.6%) cases were reported in the individual database 
during 2004–2014; the proportion of laboratory-confirmed 
cases ranged from 76.9% in 2004 to 93.2% in 2014 (Table; 
Figure 2). Most cases during 2004–2014 occurred in males; 
the male:female ratio was 2.9:1 for both northern (2.9:1) 
and southern (2.6:1) China (Table; online Technical Ap-
pendix Table 6). Median age of case-patients was 44 years 
(IQR 34–54 years), and case distribution was similar by sex 
and type of diagnosis and between northern and southern 
China (Figure 2). Most (88.8%) case-patients were farmers 
or veterinarians or worked in livestock husbandry, trans-
portation, and trade or food production during 2004–2014.
Overall Incidence and Seasonality
The annual incidence rate fluctuated during the 60 years 
studied (Figure 1, panel A). Before 1979, human brucel-
losis incidence was relatively steady (IQR 0.4–1.0 cas-
es/100,000 residents) and peaked during 1957–1963 (range 
0.9–1.8/100,000) and again during 1969–1971 (range 
1.0–1.2/100,000). Incidence decreased dramatically be-
ginning in 1979 and remained low until 1994 (IQR 0.05–
0.10/100,000). However, the incidence increased from 
1995 through 2014 (median 0.2/100,000 [IQR 0.1–0.2] 
during 1995–2003 and 2.5/100,000 [IQR 1.5–2.9] during 
2004–2014); incidence was highest (4.2 cases/100,000 
residents) in 2014. After removal of the excess proportion 
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Figure 1. Reported human brucellosis cases (N = 513,034), mainland China, 1955–2014. A) Aggregated number of cases (blue bars) 
and annual incidence rate (orange line) per 100,000 residents reported by year. The adjusted incidence rate (green dashed line) was 
estimated by an excess proportion (22.06%) that might be attributed to the effect of Internet-based reporting since 2004 (see Methods). 
B) Forecast of the monthly number of cases (blue line) during 2015–2019 by Holt-Winters exponential smoothing with 80% CIs (light 
gray) and 95% CIs (dark gray) based on monthly numbers for 2004–2014.
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(22.1%; online Technical Appendix Figure 1) to account 
for the potential effect of improvements in data reporting 
since 2004, the adjusted incidence rate still indicated an 
average annual growth rate of 20.8% during 2003–2014, 
and it appears that brucellosis incidence will continue to 
rise during the next 5 years (Figure 1, panel B). Addition-
ally, 69.1% (258,462/374,141) of the cases were reported 
in February–July during 1990–2014, with an obvious sea-
sonality in northern China in 2005–2014 (Figure 3).
Geographic Distribution
Most (99.3%) cases were reported in northern China dur-
ing 1955–2014, and most provinces in northern China 
experienced a serious epidemic during the 1950s through 
the 1970s. Incidence subsequently decreased from the late 
1970s through the early 1990s and the disease reemerged in 
the mid-1990s with cases reported almost every year (Fig-
ure 3; online Technical Appendix Figure 2). The 5 prov-
inces with the highest median incidence rates during 1955–
1994 were Tibet (14.07 cases/100,000 residents), Qinghai 
(4.43), Shanxi (0.87), Xinjiang (0.35), and Inner Mongolia 
(0.35); during 1995–2014, highest incidences shifted to In-
ner Mongolia (25.80), Shanxi (7.33), Heilongjiang (6.07), 
Jilin (1.79), and Hebei (1.40).
Similarly, the incidence in southern China has in-
creased since 2000, and human brucellosis has emerged or 
reemerged in all provinces of southern China. Cases have 
been reported in almost every province and year since 2010. 
This finding contrasts with the distribution of brucellosis 
before 2000, when the disease was limited to a few prov-
inces in southern China, such as Sichuan, Guangxi, and 
Guangdong (Figures 3, 4; online Technical Appendix Fig-
ure 2). Additionally, the proportion of imported cases was 
higher in southern than northern China (58.5% vs. 40.5%; 
p<0.001), but cases in southern China had a longer lag from 
illness onset to diagnosis than did those in northern China 
(21 vs. 20 days; p = 0.003) (Table).
Correspondingly, the number of counties reporting hu-
man cases in mainland China increased from 87 in 1993 
to 1,723 in 2014; each year since 2004, hundreds of coun-
ties were newly affected (Figures 5, 6). The proportion of 
counties affected in southern China increased from 1.1% 
in 2004 to 20.5% in 2014, highlighting the spatial spread 
over the past decade. From a land cover perspective, dur-
ing 2004–2014, affected areas seem to have expanded from 
the provinces in northern pastureland areas to the adjacent 
grassland and agricultural areas that have a high density 
of sheep and goats, then to coastal areas and southeastern 
China (Figure 6).
Discussion
We used a longitudinal surveillance dataset spanning 60 
years in China to investigate changes in the epidemiologic 
characteristics of human brucellosis, especially during the 
period of dramatic socioeconomic changes during the past 
3 decades, during which the urban population increased 
from 19% in 1980 to 54% in 2014 (30). Human brucello-
sis has reemerged in mainland China since the mid-1990s; 




Table. Characteristics of persons with brucellosis, mainland China, 2004–2014* 
Characteristic Total, N = 346,682 Northern China, n = 344,204 Southern China, n = 2,478 
Type of case 
 Confirmed 314,694 (90.8) 312,371 (90.8) 2,323 (93.7) 
 Probable 31,988 (9.2) 31,833 (9.2) 155 (6.3) 
Sex 
 M 42,912 (73.8) 42,166 (73.9) 746 (71.0) 
 F 15,230 (26.2) 14,926 (26.1) 304 (29.0) 
Age, y 
 Median (IQR) 44.0 (34.1–53.9) 44.0 (34.1–53.9) 46.6 (36.6–56.1) 
 Age group 
   
  0–4 2,424 (0.7) 2,402 (0.7) 22 (0.9) 
  5–14 6,638 (1.9) 6,596 (1.9) 42 (1.7) 
  15–24 25,262 (7.3) 25,108 (7.3) 154 (6.2) 
  25–34 57,651 (16.6) 57,313 (16.7) 338 (13.6) 
  35–44 90,777 (26.2) 90,209 (26.2) 568 (22.9) 
  45–54 87,566 (25.3) 86,901 (25.2) 665 (26.8) 
  55–64 57,274 (16.5) 56,765 (16.5) 509 (20.5) 
  >65 19,090 (5.5) 18,910 (5.5) 180 (7.3) 
Median delay, d (IQR) 
 From illness onset to diagnosis 20.0 (7.5–42.0) 20.0 (7.5–42.0) 20.7 (8.5–47.5) 
 From diagnosis to report 0.25 (0.04–0.65) 0.25 (0.04–0.65) 0.15 (0.04–0.66) 
 From illness onset to report 20.6 (7.8–43.4) 20.6 (7.8–43.4) 19.5 (8.0–44.7) 
Origin of imported case 
 Same county 205,941 (59.4) 204,912 (59.5) 1,029 (41.5) 
 Other county of same prefecture 92,351 (26.6) 91,628 (26.6) 723 (29.2) 
 Other prefecture of same province 32,584 (9.4) 32,088 (9.3) 496 (20) 
 Other province 15,806 (4.6) 15,576 (4.5) 230 (9.3) 
*The list of provinces in northern and southern China is available in online Technical Appendix Table 5, https://wwwnc.cdc.gov/EID/article/23/3/16-1710-
Techapp1.pdf. Data are presented as no. (%) patients unless otherwise indicated. IQR, interquartile range. 
 
SYNOPSIS
incidence has increased and the disease has expanded geo-
graphically from northern to southern China. Our study, 
with long-term and high-quality incidence data, comple-
ments a previously published map of human brucellosis in 
East Asia (2–4).
The temporal trend in human brucellosis incidence in 
this study (i.e., high incidence during 1955–1978, low in-
cidence during 1979–1994, and high (and increasing) in-
cidence from 1995 onwards) is consistent with the trend 
in Brucella spp. seroprevalance from animal and human 
serosurveys conducted in China during 1950–2014. An 
overall seroprevalence of 41.27% in cattle, sheep, and 
pigs in brucellosis-endemic areas and 8.43% in humans 
was reported for 1952–1981, but seroprevalence was only 
0.55% in animals and 0.75% in humans during1982–1990 
after implementation of a national control program in 1979 
(14,31). During 1990–2001, seroprevalence in humans was 
3.28% and has increased steadily since 1995, despite the 
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Figure 2. Age distribution and proportion of 346,682 human brucellosis patients, mainland China, 2004–2014. A) Age distribution by 
sex. B) Annual proportion of patients by sex. C) Age distribution of persons with probable and confirmed cases. D) Annual proportion of 
probable and confirmed cases. E) Age distribution of patients in northern and southern China. F) Proportion of cases in northern and 
southern China each year.
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lack of obvious change in domestic animals (0.36%) (16). 
In the 21st century, seroprevalence maintained an increas-
ing trend in occupationally exposed populations (11.36% 
during 2001–2004, 13.31% during 2005–2006, 21.97% in 
2007, and 22.75% in 2011) and livestock (0.28% during 
2001–2004, 0.72% during 2005–2006, and 1.49% in sheep 
in 2009) (32–35). Although incidence appeared to increase 
in every province, Tibet seems to follow an inverse pattern 
and reported few cases during the past 10 years, but sero-
logic surveys indicate that seroprevalence of Brucella in-
fection in animals and humans remained high in some areas 
since 2005 (36). Additionally, this study found a low case-
fatality rate in passive surveillance, and the poor follow-up 
for outcomes of human brucellosis with chronic infection 
and illness might have contributed.
After brucellosis reemerged in China, the geographic 
distribution of affected areas gradually expanded (14). The 
areas of brucellosis endemicity gradually shifted from pas-
turing areas (i.e., Inner Mongolia, Xinjiang, Tibet, Qing-
hai, and Ningxia) to grassland and agricultural areas (i.e., 
Shanxi, Liaoning, Hebei, Shandong, and Jilin Provinces), 
and the southern provinces became increasingly affected 
(Figures 4, 6) (14,17). This reemergence and the geograph-
ic expansion might be attributed to a variety of contribut-
ing factors.
Because brucellosis is not transmitted among humans, 
humans can be a sentinel for livestock brucellosis. For ev-
ery human brucellosis case, 15 B. melitensis cases are ex-
pectedin small ruminants or 150 B. abortus cases in cattle 
(37), and the large population of reservoir animals infected 
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Figure 3. Heat map of provinces with human brucellosis cases, by north and south and the latitude of the capital city of each province, 
China. A) Time series of incidence rate per 100,000 residents during 1955–2014, standardized by the eighth root. B) Time series of 
monthly cases, 2005–2014, standardized by the annual number of cases reported by each province. C) Seasonal distribution of cases 
by province, plotted as the mean value of the proportion of cases in each week of the year from 2005 through 2014.
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Figure 4. Geographic distribution of the annual incidence rate 
per 100,000 residents of human brucellosis by 5-year periods, 
mainland China, 1990–2014.
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with Brucella spp. provides a source and is likely to be one 
of the main causes of infection for humans. The number of 
livestock dramatically increased during the past 3 decades 
to meet the growing demand for meat in China (e.g., the 
yearly numbers of cattle for meat production increased from 
3.3 million in 1980 to 46.7 million in 2011, and numbers of 
sheep and goats increased 6-fold) (38), which would have 
resulted in an increase of the total population of infected 
animals, even with low-level constant seroprevalence in 
livestock. The spatial distribution of human brucellosis ap-
parently overlaps with livestock density, especially high 
densities of sheep and goats (Figure 6), and high incidences 
of human brucellosis tended to occur most commonly in 
grasslands at moderate elevation, where sheep and goats are 
the predominant livestock (17,39). Another possible reason 
for the reemergence is the lack of vaccination, quarantine, 
and elimination of infected animals among backyard live-
stock. Moreover, the intensive modes of production, which 
accounted for the rearing of only 42.9% of cattle and 51.1% 
of sheep and goats in 2011, along with poor infrastructure 
and lack of high-standard and standardized protocols for 
maintaining good hygiene within the production cycle, 
might also result in increasing infections (38). Hence per-
sons engaged in livestock husbandry, production, and trade 
are at high risk for brucellosis infection because of occu-
pational exposure. Additionally, animal products supplied 
from brucellosis-endemic areas that have not undergone 
quarantine or pasteurization might increase the risk for 
infection in nonoccupational populations and urban set-
tings, taking a longer time from illness to diagnosis for im-
ported cases in southern China, which might create extra 
challenges for disease prevention and case management 
(19,20,40). Therefore, susceptible livestock animals as the 
host and infection source for human infections are key to 
brucellosis prevention and control.
Vaccination is an effective method to reduce brucel-
losis incidence in livestock and correlates to a decrease in 
reported human cases, although no vaccines are available 
for humans (37,41). Compared with those from other coun-
tries, new sequence types of Brucella strains have been 
found in China, and the predominant biovars and sequence 
types of Brucella strains has changed during past half cen-
tury in some regions (42). Thus, new livestock vaccines 
different from those recommended by the International Of-
fice of Epizootics are needed in China.
Targets have been set for brucellosis control in animals 
in 2015 and 2020 to reach the standard of control and de-
contamination by province (online Appendix Table 7) (25). 
However, to achieve the targets for brucellosis reduction, 
improvements are needed in socioeconomic parameters, 
diagnostic and notification systems in animals and humans, 
and the high prioritization for eliminating the disease in 
livestock. The continuing existence of human (and animal) 
brucellosis in China, with potential for further increases 
in incidence, indicates that the control of brucellosis will 
not be an easy task without taking a One Health approach, 
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Figure 5. Number of counties with human brucellosis cases, mainland China, 2004–2014. A) Total number of affected counties each 
year and number of newly affected counties since 2004. B) Total number of affected counties each year in northern and southern China.
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Figure 6. Geographic expansion of human brucellosis across counties and distribution of land covers (28) and density of sheep and 
goats (29), mainland China, 2004–2014.
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integrating health professionals from the human and animal 
sectors and administrations. This effort extends beyond 
medical and veterinary duties and encompasses economic 
and even political factors (2).
Our study has some limitations. First, the data used 
were collected from passive public health surveillance that 
might be influenced by changes in surveillance protocols, 
such as modifications in case definitions and laboratory 
tests, reporting methods, and availability of health facilities 
and laboratory diagnostics over the years (online Techni-
cal Appendix Table 4). Second, individual case data were 
not reported before 2004, so demographic characteristics, 
laboratory confirmation, and case distribution could be an-
alyzed only for 2004–2014. Third, data on Brucella strains 
and biotypes and on the varied clinical presentations, in-
cluding asymptomatic brucellosis infections among hu-
mans, were unavailable in this study to explore the distri-
bution of pathogens and the severity of disease. However, 
the data we used were the most nationally comprehensive 
for human brucellosis in China.
In view of the reemergence of brucellosis in mainland 
China and the high incidence, further studies should be 
conducted to explore the drivers of this situation during the 
past 2 decades. Livestock–human seroprevalence surveys 
are needed to understand the correlation between livestock 
and human brucellosis, to identify the most important ani-
mal host species, and to attempt to regress human serop-
revalence to livestock prevalence or simply livestock num-
bers (43). The application of spatial–temporal transmission 
modeling, linking environmental and socioeconomic vari-
ables and density (e.g., http://www.worldpop.org) and mo-
bility of livestock and humans (44) with the seroprevalence 
data, would improve understanding of the factors driving 
reemergence of brucellosis and enable us to better predict 
the risk in space and time. This information could further 
inform on potential causes of reemergence (45,46) and the 
economics of control in relation to ongoing control activi-
ties in China.
In summary, on the basis of notifiable surveillance 
data in mainland China during 1955–2014, we found that 
human brucellosis has reemerged since the mid-1990s, and 
the affected areas have expanded from northern to southern 
China, especially since 2004. Control strategies in animals 
and humans should be adjusted to account for these chang-
es by adopting a One Health approach at different levels. 
Further research is warranted to explore the drivers behind 
the reemergence.
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